PT2933251T - Composição farmacêutica que pode ser utilizada para o tratamento de uma patologia do pé de um mamífero ungulado - Google Patents
Composição farmacêutica que pode ser utilizada para o tratamento de uma patologia do pé de um mamífero unguladoInfo
- Publication number
- PT2933251T PT2933251T PT151634540T PT15163454T PT2933251T PT 2933251 T PT2933251 T PT 2933251T PT 151634540 T PT151634540 T PT 151634540T PT 15163454 T PT15163454 T PT 15163454T PT 2933251 T PT2933251 T PT 2933251T
- Authority
- PT
- Portugal
- Prior art keywords
- ungulated
- pathology
- mammalian
- foot
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1453382A FR3019820B1 (fr) | 2014-04-15 | 2014-04-15 | Composes de type flavonoides pour leur utilisation dans le traitement d'une pathologie du pied d'un mammifere ongule-composition pharmaceutique associee |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2933251T true PT2933251T (pt) | 2021-08-13 |
Family
ID=51483548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT151634540T PT2933251T (pt) | 2014-04-15 | 2015-04-14 | Composição farmacêutica que pode ser utilizada para o tratamento de uma patologia do pé de um mamífero ungulado |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2933251B1 (pt) |
| ES (1) | ES2881547T3 (pt) |
| FR (1) | FR3019820B1 (pt) |
| MA (1) | MA38619A (pt) |
| PT (1) | PT2933251T (pt) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2710844B1 (fr) * | 1993-10-07 | 1995-12-29 | Bidel Christian Georges | Composition pour le traitement ou la prévention de l'herpès. |
| US6528042B1 (en) * | 1999-10-08 | 2003-03-04 | Galileo Laboratories, Inc. | Compositions of flavonoids for use as cytoprotectants and methods of making and using them |
| US20030125264A1 (en) * | 2001-12-29 | 2003-07-03 | Kimberly-Clark Worldwide, Inc. | Methods For Treating Wounds |
| AU2004298356A1 (en) * | 2003-12-18 | 2005-06-30 | Nestec S.A. | Composition for improving skin, hair and coat health containing flavanones |
| GB0505756D0 (en) * | 2005-03-21 | 2005-04-27 | Mars Uk Ltd | Method |
| US20080317885A1 (en) * | 2005-07-15 | 2008-12-25 | Baker Donald J | Compositions and Methods for Treating and Preventing Inflammatory and/or Degenerative Processes in Humans and Other Animals |
| ITMI20052461A1 (it) * | 2005-12-22 | 2007-06-23 | Univ Degli Studi Milano | Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive |
| DE502007002101D1 (de) * | 2007-03-12 | 2010-01-07 | Dobavet Gmbh | Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen |
| MX2007011002A (es) * | 2007-09-07 | 2009-03-09 | World Trade Imp Export Wtie Ag | Composicion farmaceutica que comprende la combinacion de diversos agentes venotonicos y vasoprotectores para el tratamiento de la insuficiencia venosa cronica. |
| US8557275B2 (en) * | 2009-07-23 | 2013-10-15 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA |
| EP2353596A1 (en) * | 2010-02-02 | 2011-08-10 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency |
| FI20106119A0 (fi) * | 2010-10-27 | 2010-10-27 | Sirtuin Valley Oy | Energia-aineenvaihduntaan vaikuttava koostumus |
-
2014
- 2014-04-15 FR FR1453382A patent/FR3019820B1/fr not_active Expired - Fee Related
-
2015
- 2015-04-14 PT PT151634540T patent/PT2933251T/pt unknown
- 2015-04-14 ES ES15163454T patent/ES2881547T3/es active Active
- 2015-04-14 MA MA038619A patent/MA38619A/fr unknown
- 2015-04-14 EP EP15163454.0A patent/EP2933251B1/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MA38619A (fr) | 2021-06-02 |
| EP2933251A1 (fr) | 2015-10-21 |
| FR3019820A1 (fr) | 2015-10-16 |
| EP2933251B1 (fr) | 2021-07-07 |
| ES2881547T3 (es) | 2021-11-29 |
| FR3019820B1 (fr) | 2017-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3493799A4 (en) | CANNABIS | |
| EP3476386C0 (en) | LIQUID PHARMACEUTICAL COMPOSITION | |
| DK3256138T3 (da) | Farmaceutiske sammensætninger omfattende meloxicam | |
| EP3513809A4 (en) | MEDICAL COMPOSITION | |
| EP3493798A4 (en) | CANNABIS | |
| DK3532029T3 (da) | Flydende farmaceutisk sammensætning | |
| DK3102213T3 (da) | Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser | |
| MA54716A (fr) | Réduction de la viscosité de formulations pharmaceutiques | |
| DK3237045T3 (da) | Indretning til indgivelse af lægemidler | |
| LT3116491T (lt) | Terapiškai aktyvių junginių farmacinės kompozicijos | |
| BR112016021034A2 (pt) | Composição farmacêutica, uso de tal composição, método para tratar uma doença e kit | |
| DK3554534T3 (da) | Farmaceutisk sammensætning omfattende insulin | |
| BR112016020181A2 (pt) | Composições de ácido lipoico éster colina e métodos de uso. | |
| BR112016020260A2 (pt) | uso de um composto na fabricação de um medicamento para tratar uma doença colestática intra-hepática | |
| PL3207149T3 (pl) | Kompozycja farmaceutyczna o zwiększonej stabilności | |
| EP3402470A4 (en) | STABLE PHARMACEUTICAL COMPOSITION | |
| PT3360547T (pt) | Composição farmacêutica bactericida que compreende ibuprofeno | |
| PT3094616T (pt) | O uso de uma composição que contém tribenzoato de glicerilo em distúrbios neurodegenerativos | |
| EP3383371A4 (en) | PHARMACEUTICAL FORMULATION | |
| BR112017007753A2 (pt) | uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico. | |
| BR112016030507A2 (pt) | Compostos relacionados à vitamina d, composição farmacêutica, e kit | |
| DK3313370T3 (da) | Oftalmologisk farmaceutisk sammensætning | |
| DK3096775T5 (da) | SOCS-mimetika til behandling af sygdomme | |
| EP3524250A4 (en) | PHARMACEUTICAL COMPOSITION | |
| PL3203998T3 (pl) | Podstawione związki aromatyczne i kompozycje farmaceutyczne do zapobiegania i leczenia cukrzycy |